GlobalData Plc

🌐 Dive into the future of Tech, Media, and Telecom (TMT) with our latest report! 📊 Unlock insights into the 40 most impactful themes driving the industry in 2024. From AI to Cybersecurity, China to Batteries, and Inflation, we've got you covered. 💡 Our thematic framework simplifies complex data, empowering your strategic decisions. Get ahead of the curve with quantitative forecasts and qualitative analysis for each theme. 📈 Explore infographics validating predictions, sourced from extensive databases including patents, jobs, deals, filings, and social media analytics. 🏆 Identify winners and losers using our unique thematic methodology. https://lnkd.in/g-z9jky6 #tech #media #telecom #TMT #Predictions2024

Grounded by poor management and a myriad of #safety disasters, #Boeing has experienced severe turbulence in recent years. #airport #plane For the full version of #DECODED #Travel & #Tourism, subscribe here: https://lnkd.in/esk7bD3u

Exciting insights from GlobalData's Technology Foresight reveal the next big wave of disruption in insurance, driven by Artificial Intelligence (AI)! 🔄Integrating AI models with actuarial sciences, insurers are revolutionizing risk analysis and claim processing workflows”, the key message is that this is a well-established practice in the insurance industry but now AI is going beyond these regular tasks. Sourabh Nyalkalkar Practice Head of Innovation Products at GlobalData highlights the diverse applications emerging in personal and health insurance. 💡 Tractable, with a $65M investment from SoftBank Investment Advisers, leads the charge with groundbreaking computer vision tech for swift damage assessment. Explore more: https://lnkd.in/g9TDjnYK #technology #InsurTech #AIinInsurance #Innovation #insurance #ai

🌟 Exciting insights from Google Cloud Next 2024! Despite past challenges, Google shines with its engineering prowess 💡. At the conference, Google emphasized its commitment to innovation, particularly in emerging tech like GenAI 🤖 and cloud-native solutions like Kubernetes ☁️. With a focus on enterprise developers, Google aims to elevate coding, platforms, and operations with its Gemini-backed initiative 🚀. Check out the article by Charlotte Dunlap Research Director at GlobalData: https://lnkd.in/gitA-eiS #TechInnovation #GoogleNext2024 #cloud #google #genai 

Subscribe to #DECODED for expert industry insights, forecasts, and opinions from leading journalists & best-in-class datasets. 💡 Sign-up now:

🚨 Legal Action Alert! 🚨 Bausch Health Companies Inc. and Salix Pharmaceuticals, Inc. are taking a stand against Amneal Pharmaceuticals with a lawsuit filed in the U.S. District Court for the District of New Jersey. 💼 Why? Amneal's Abbreviated New Drug Application (ANDA) for a generic version of XIFAXAN (rifaximin) 550 mg tablets has triggered a response. Bausch Health asserts the importance of protecting its XIFAXAN franchise, standing firm on its intellectual property rights. 💪 Thomas J. Appio, CEO of Bausch Health, reaffirms the company's confidence in XIFAXAN's intellectual property, stressing its critical role in continuing to deliver innovative therapies for patients. 🌟 This isn't the first rodeo for Bausch Health. Previous Paragraph IV Certifications from Teva Pharmaceuticals, Sandoz Inc., Sun Pharmaceuticals, and Norwich Pharmaceuticals have been dealt with through settlements and ongoing litigation. 🔍 XIFAXAN® (rifaximin) 550 mg tablets aren't just any medication - they're vital for reducing the risk of hepatic encephalopathy recurrence and treating irritable bowel syndrome with diarrhea in adults. 🩺 📊 GlobalData analysis from the Patent Analytics tool shows the key players with publications to treat Hepatic Encephalopathy. ⚡Connect with us today to explore the endless possibilities and propel your business forward! 📧 patents@globaldata.com or ☎ explore more at our contact page: https://lnkd.in/ggfMtshS #patents #healthcare #pharma #pharmaceuticals #health

The risk of serious injury and death is a sad reality in #mining, but #technology can help reduce accidents and improve emergency response. #SAR #searchandrescue For more on topics like this, subscribe to #DECODED mining here: https://lnkd.in/eKFpxFne

💡 Are you prepared to adapt to the evolving geopolitical landscape? 🌍GlobalData’s latest Thematic Intelligence report offers a systematic analysis of the varying types of business exposure to geopolitical shocks as an aid to risk management and spotting associated opportunities. With tensions rising in key regions, navigating economic, political, and security dynamics is more challenging than ever. 🛡️ 👉 Explore more here: https://lnkd.in/gAYDKfKB 👉 Read our latest article featuring insights from Christopher Granville and Carolina Pinto: https://lnkd.in/gRaZkyKR #Geopolitics #BusinessStrategy #RiskManagement #Globalbusiness #Challenges #Economic #Political #automotive #consumer #retail #financialservices #Energy

Oncology in 2024: CROs are going to be in demand for oncology trials this year. Data from GlobalData’s Clinical Trials Intelligence Center highlights how oncology is the top therapy area for both trials planned or expected to complete in 2024. CROs are fundamental to the development of cancer treatments but face multiple challenges. Walker Bradham, Zelta product leader at Merative analyzes the biggest trends in oncology and the technological solutions available to CROs to optimize efficiencies. 👉 Explore more here : https://lnkd.in/gHnt2UfQ Zelta by Merative #clinicaltrials #cancerresearch #CRO #HealthcareInnovation #PharmaIndustry #HealthTech #Oncology

Are you ready to understand apparel consumers? 💡 Register for our webinar today! 👉 https://lnkd.in/eTD_C9Uk As economic turbulence continues to restrict apparel spending, knowing their priorities, attitudes, and behaviors will be crucial. Let us advise you! Join our free webinar on 18th April to see data-backed analysis about top trends within the global apparel market, including our proprietary consumer research.